A new trading day began on Friday, with Precigen Inc (NASDAQ: PGEN) stock price down -4.19% from the previous day of trading, before settling in for the closing price of $1.91. PGEN’s price has ranged from $0.65 to $2.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 25.76% over the past five years. Meanwhile, its annual earnings per share averaged 25.00%. With a float of $146.25 million, this company’s outstanding shares have now reached $295.14 million.
Let’s look at the performance matrix of the company that is accounted for 143 employees. In terms of profitability, gross margin is -2.17%, operating margin of -3171.03%, and the pretax margin is -3770.86%.
Precigen Inc (PGEN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Precigen Inc is 50.45%, while institutional ownership is 27.30%. The most recent insider transaction that took place on Aug 09 ’24, was worth 50,000. In this transaction SVP, IP Affairs of this company bought 58,823 shares at a rate of $0.85, taking the stock ownership to the 743,097 shares. Before that another transaction happened on Aug 09 ’24, when Company’s Director bought 23,529,411 for $0.85, making the entire transaction worth $19,999,999. This insider now owns 64,547,214 shares in total.
Precigen Inc (PGEN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 25.00% per share during the next fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Here are Precigen Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 128.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Precigen Inc (NASDAQ: PGEN) saw its 5-day average volume 3.11 million, a positive change from its year-to-date volume of 1.84 million. As of the previous 9 days, the stock’s Stochastic %D was 75.30%.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 67.92%, which indicates a significant increase from 67.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1133 in the past 14 days, which was lower than the 0.1295 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4666, while its 200-day Moving Average is $1.2820. Nevertheless, the first resistance level for the watch stands at $1.8967 in the near term. At $1.9633, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0067. If the price goes on to break the first support level at $1.7867, it is likely to go to the next support level at $1.7433. Assuming the price breaks the second support level, the third support level stands at $1.6767.
Precigen Inc (NASDAQ: PGEN) Key Stats
With a market capitalization of 540.18 million, the company has a total of 295,180K Shares Outstanding. Currently, annual sales are 3,930 K while annual income is -126,240 K. The company’s previous quarter sales were 1,340 K while its latest quarter income was -54,150 K.
